mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.009 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.009 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.01 |
mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.01 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.01 |